Tag: lymphocytic lymphoma

Lilly announces promising results for Pirtobrutinib Phase 1/2 trials

businessnewstoday- July 7, 2023

Eli Lilly's oncology arm, Loxo@Lilly, disclosed that The New England Journal of Medicine (NEJM) has published an extensive analysis of results from the BRUIN Phase ... Read More

BeiGene gets Brukinsa FDA approval for chronic lymphocytic leukemia

Raghuram Kadari- January 21, 2023

BeiGene has secured the approval of the US Food and Drug Administration (FDA) for the company’s Brukinsa (zanubrutinib) for the treatment of adult patients with ... Read More

Ascentage Pharma gets FDA ODD for APG-2575 in Waldenström macroglobulinemia

pharmanewsdaily- July 16, 2020

Ascentage Pharma has been granted orphan drug designation (ODD) for its Bcl-2 inhibitor APG-2575 from the US Food and Drug Administration (FDA) for the treatment ... Read More